U.S. Markets open in 36 hrs, 39 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 22.61 09:30 AM EST | |
|---|---|---|
| Day High | 23.00 09:56 AM EST |
|
| Range | 0.39 |
| Volume | 619,236 | |
|---|---|---|
| 30-Day Avg Vol | 1.53 M |
|
| Difference | -59.53% |
| Market Cap | 2.69 B | |
|---|---|---|
| Mkt Cap Chg | 12.89 M |
| Shares Out | 117.25 M | |
|---|---|---|
| % Shrs Traded | 0.53% | |
| 1yr EPS Est | 2.765 |
| 52-Wk Low | 15.75 | |
|---|---|---|
| 52-Wk High | 26.14 |
|
| Range | 10.39 |
| Prev Close | 22.89 11/5/09 | |
|---|---|---|
| Today's Open | 22.89 | |
| Change | 0.00% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 6.34 M |
| Revenue (LFY) | 1.26 B | |
|---|---|---|
| Earnings (LFY) | 261.74 M | |
| Earnings (MRQ) | 49.42 M | |
| Next Earn Est | 0.683 | |
| Next Earnings | 02/22/2010 |
|
| EPS (TTM) | 1.64 | |
| 1yr EPS Growth | 1.65% |
| P/E Ratio (TTM) | 13.69 | |
|---|---|---|
| P/E Ratio (Fwd) | 8.30 | |
| PEG Ratio | 0.83 | |
| Return on Equity | 19.50 | |
| Beta | 0.48 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Endo Pharmaceuticals wants the pain to end, preferably through the drugs it acquires and markets. The pharmaceutical company has a portfolio of both branded and generic prescription products for pain management. ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.683 2/22/10 | — — |
—
—
|
| Last Quarter | 0.645 9/30/09 | 0.63 9/30/09 |
-0.015
Missed
|
| 2 Quarters Ago | 0.667 6/30/09 | 0.73 6/30/09 |
0.063
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 361.03 M | 1.26 B |
| Gross Profit | 263.72 M | 993.30 M |
| Operating Income | 64.11 M | 395.03 M |
| Net Income | 49.42 M | 261.74 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts